Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05371> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05371 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05371 label "ACR-16 [drugbank:DB05371]" assertion.
- drugbank:DB05371 seeAlso DB05371 assertion.
- drugbank:DB05371 description "ACR-16 is under investigation by NeuroSearch. ACR16 has been successfully investigated in a Phase II multi-centre, randomised and placebo-controlled trial in patients with Huntingtonâs disease as well as in three Phase Ib studies within Huntingtonâs disease, Parkinsonâs disease and schizophrenia respectively. ACR-16 is a dopamine stabilizer. ACR-16 is also being studied in other psychiatric and neurologic diseases." assertion.
- drugbank:DB05371 identifier "drugbank:DB05371" assertion.
- drugbank:DB05371 title "ACR-16" assertion.
- drugbank:DB05371 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05371 drugbank_vocabulary:drugbank-id "DB05371" assertion.
- drugbank:DB05371 bio2rdf_vocabulary:x-identifiers.org DB05371 assertion.
- drugbank:DB05371 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05371" assertion.
- drugbank:DB05371 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05371 bio2rdf_vocabulary:identifier "DB05371" assertion.